These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 339659)

  • 21. Efficacy of nimodipine in the prophylaxis of migraine.
    Havanka-Kanniainen H; Hokkanen E; Myllylä VV
    Cephalalgia; 1985 Mar; 5(1):39-43. PubMed ID: 3886153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial.
    Tfelt-Hansen P; Standnes B; Kangasneimi P; Hakkarainen H; Olesen J
    Acta Neurol Scand; 1984 Jan; 69(1):1-8. PubMed ID: 6367336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of acute migraine attack: ibuprofen and placebo compared.
    Havanka-Kanniainen H
    Headache; 1989 Sep; 29(8):507-9. PubMed ID: 2676908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of clonidine in the treatment of migraine: a review of the literature and personal experience.
    Hakkarainen H; Kokkanen E; Kallanranta T
    Ups J Med Sci Suppl; 1980; 31():16-9. PubMed ID: 7006181
    [No Abstract]   [Full Text] [Related]  

  • 25. Classic migraine: effective prophylaxis with metoprolol.
    Kangasniemi P; Andersen AR; Andersson PG; Gilhus NE; Hedman C; Hultgren M; Vilming S; Olesen J
    Cephalalgia; 1987 Dec; 7(4):231-8. PubMed ID: 3322569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cimetidine in the prophylaxis of migraine.
    Nanda RN; Arthur GP; Johnson RH; Lambie DG
    Acta Neurol Scand; 1980 Aug; 62(2):90-5. PubMed ID: 7010874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing the Effects of Atorvastatin With Sodium Valproate (Divalproex) on Frequency and Intensity of Frequent Migraine Headaches: A Double-blind Randomized Controlled Study.
    Hesami O; Sistanizad M; Asadollahzade E; Johari MS; Beladi-Moghadam N; Mazhabdar-Ghashghai H
    Clin Neuropharmacol; 2018; 41(3):94-97. PubMed ID: 29746282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Migraine prevention with timolol. A double-blind crossover study.
    Stellar S; Ahrens SP; Meibohm AR; Reines SA
    JAMA; 1984 Nov; 252(18):2576-80. PubMed ID: 6387197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial.
    Tronvik E; Stovner LJ; Helde G; Sand T; Bovim G
    JAMA; 2003 Jan; 289(1):65-9. PubMed ID: 12503978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
    Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
    CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic treatment of migraine with tolfenamic acid. A comparative double-blind crossover study between tolfenamic acid and placebo.
    Mikkelsen BM; Falk JV
    Acta Neurol Scand; 1982 Jul; 66(1):105-11. PubMed ID: 7051739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Femoxetine in the prophylaxis of migraine--a randomised comparison with placebo.
    Zeeberg I; Orholm M; Nielsen JD; Honore PL; Larsen JJ
    Acta Neurol Scand; 1981 Dec; 64(6):452-9. PubMed ID: 6753446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A placebo-controlled crossover trial of nimodipine in pediatric migraine.
    Battistella PA; Ruffilli R; Moro R; Fabiani M; Bertoli S; Antolini A; Zacchello F
    Headache; 1990 Apr; 30(5):264-8. PubMed ID: 2191938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Headache and noradrenergic involvement: the effects of alpha 2-stimulants and alpha 2-antagonists.
    Denaro A; Martucci N; Ruggieri S; Manna V; Agnoli A
    Acta Psychiatr Scand Suppl; 1985; 320():20-5. PubMed ID: 3901672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study.
    Jensen R; Brinck T; Olesen J
    Neurology; 1994 Apr; 44(4):647-51. PubMed ID: 8164818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A quantification of the placebo response in migraine prophylaxis.
    van der Kuy PH; Lohman JJ
    Cephalalgia; 2002 May; 22(4):265-70. PubMed ID: 12100088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A placebo-controlled, double-blind, cross-over trial of flunarizine in common migraine.
    Sørensen PS; Hansen K; Olesen J
    Cephalalgia; 1986 Mar; 6(1):7-14. PubMed ID: 3516409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pirprofen in the treatment of migraine and episodic headache attacks: a placebo-controlled crossover clinical trial.
    Guidotti M; Zanasi S; Garagiola U
    J Int Med Res; 1989; 17(1):48-54. PubMed ID: 2651177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.